The effectiveness of sodium-glucose co-transporter 2 inhibitors on cardiorenal outcomes: an updated systematic review and meta-analysis.

Journal Information

Full Title: Cardiovasc Diabetol

Abbreviation: Cardiovasc Diabetol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Vascular Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations DisclosuresAll screening of articles, data extraction, analysis, and interpretation was conducted by MERST members, independent from the guideline Committee or funders. All authors contributed to the writing or editing of the manuscript. Disclosures All screening of articles, data extraction, analysis, and interpretation was conducted by MERST members, independent from the guideline Committee or funders. All authors contributed to the writing or editing of the manuscript."

Evidence found in paper:

"Funding Dr. Diana Sherifali holds the Heather M Arthur Population Health Research Institute/Hamilton Health Sciences Chair in Interprofessional Health Research which supported this work."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025